13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001193125-26-054833
Total Value
$1.31B
Positions
19
Other Managers
14
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HEARTFLOW INC | HTFL | 12,448,158 | $362.9M | 27.79% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 7,306,566 | $256.3M | 19.63% |
| 3 | OLEMA PHARMACEUTICALS INC | OLMA | 8,508,641 | $212.7M | 16.29% |
| 4 | SAVARA INC | SVRA | 17,600,621 | $106.1M | 8.13% |
| 5 | PHARVARIS N V | PHVS | 2,802,081 | $77.8M | 5.96% |
| 6 | SOLID BIOSCIENCES INC | SLDB | 7,911,669 | $44.6M | 3.42% |
| 7 | UPSTREAM BIO INC | UPB | 1,329,544 | $36.1M | 2.76% |
| 8 | X4 PHARMACEUTICALS INC | XFOR | 7,967,454 | $31.9M | 2.44% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 743,592 | $30.6M | 2.35% |
| 10 | KYVERNA THERAPEUTICS INC | KYTX | 3,110,000 | $29.2M | 2.24% |
| 11 | ANNEXON INC | ANNX | 5,249,069 | $26.4M | 2.02% |
| 12 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $24.5M | 1.87% |
| 13 | CABALETTA BIO INC | CABA | 9,677,125 | $21.2M | 1.62% |
| 14 | C4 THERAPEUTICS INC | CCCC | 7,171,910 | $13.7M | 1.05% |
| 15 | MERSANA THERAPEUTICS INC | 59045L205 | 346,545 | $10.0M | 0.77% |
| 16 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $8.9M | 0.68% |
| 17 | TANGO THERAPEUTICS INC | TNGX | 653,493 | $5.8M | 0.44% |
| 18 | XILIO THERAPEUTICS INC | XLO | 7,372,686 | $4.7M | 0.36% |
| 19 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 99,999 | $2.3M | 0.18% |